A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic.

Journal: Journal of neurology

Publication date: 

Journal: Journal of neurology

Publication Year: 

Authors & Co-authors:  Lal Anoushka P AP Foong Yi Chao YC Sanfilippo Paul G PG Spelman Tim T Rath Louise L Levitz David D Fabis-Pedrini Marzena M Foschi Matteo M Habek Mario M Kalincik Tomas T

Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies.

Journal: Journal of neurology

Publication date: 2024

Journal: Journal of neurology

Publication Year: 2024

Authors & Co-authors:  Li Ying Y Saul Alice A Taylor Bruce B Ponsonby Anne-Louise AL Simpson-Yap Steve S Blizzard Leigh L Broadley Simon S Lechner-Scott Jeannette J Karabudak Rana R

Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom.

Journal: Journal of medical economics

Publication date: 2023

Journal: Journal of medical economics

Publication Year: 2023

Authors & Co-authors:  Spelman T T Herring W L WL Acosta C C Hyde R R Jokubaitis V G VG Pucci E E Lugaresi A A Laureys G G Havrdova E K EK Horakova D D

Stapler-Assisted Pharyngeal Closure After Total Laryngectomy: A Systematic Review and Meta-Analysis.

Journal: Oncology and therapy

Publication date: 

Journal: Oncology and therapy

Publication Year: 

Authors & Co-authors:  Chiesa-Estomba Carlos M CM Mayo-Yanez Miguel M Palacios-García Jose M JM Lechien Jerome R JR Viljoen Gerrit G Karkos Petros D PD Barillari Maria R MR González-García Jose A JA Sistiaga-Suarez Jon A JA González-Botas Jesus Herranz JH